BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11927219)

  • 1. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation.
    Vitulo P; Oggionni T; Cascina A; Arbustini E; D'Armini AM; Rinaldi M; Meloni F; Rossi A; Viganò M
    J Heart Lung Transplant; 2002 Apr; 21(4):435-9. PubMed ID: 11927219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
    Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB
    J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
    Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
    Sarahrudi K; Carretta A; Wisser W; Senbaklavaci O; Ploner M; Neuhauser P; Dobrovits M; Miwai Marta G; Papp A; Klepetko W
    Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
    Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
    Kesten S; Chaparro C; Scavuzzo M; Gutierrez C
    J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group.
    Mentzer RM; Jahania MS; Lasley RD
    Transplantation; 1998 Jan; 65(1):109-13. PubMed ID: 9448154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus as a rescue immunosuppressant after heart transplantation.
    De Bonis M; Reynolds L; Barros J; Madden BP
    Eur J Cardiothorac Surg; 2001 May; 19(5):690-5. PubMed ID: 11343954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation.
    Kur F; Reichenspurner H; Meiser BM; Welz A; Fürst H; Müller C; Vogelmeier C; Schwaiblmaier M; Briegel J; Reichart B
    Thorac Cardiovasc Surg; 1999 Jun; 47(3):174-8. PubMed ID: 10443520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
    Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
    Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
    Verleden GM; Dupont LJ; Van Raemdonck D; Vanhaecke J
    J Heart Lung Transplant; 2003 Aug; 22(8):908-13. PubMed ID: 12909472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients.
    Keenan RJ; Iacono A; Dauber JH; Zeevi A; Yousem SA; Ohori NP; Burckart GJ; Kawai A; Smaldone GC; Griffith BP
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):335-40; discussion 340-1. PubMed ID: 9040628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.